Zinc and its role in immunity and inflammation

Autoimmunity Reviews

Volumn 14, Issue 4, 2015, Pages 277-285

  Bonaventura, Paola ^a   Benedetti, Giulia ^a   Albarède, Francis ^b   Miossec, Pierre ^a  

^a University of Lyon   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Cytokines; Immune diseases; Inflammation; Metallothioneins; Rheumatoid arthritis; Zinc

Indexed keywords

NEUROTRANSMITTER; ZINC; ZINC TRANSPORTER;

ADAPTIVE IMMUNITY; APOPTOSIS; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; ENZYME ACTIVITY; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MALNUTRITION; MONOCYTE; NATURAL KILLER T CELL; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; STRUCTURE ANALYSIS; T LYMPHOCYTE; ZINC DEFICIENCY; ZINC HOMEOSTASIS; ANIMAL; DIET SUPPLEMENTATION; HOMEOSTASIS; IMMUNITY; IMMUNOLOGY; METABOLISM; PATHOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; DIETARY SUPPLEMENTS; HOMEOSTASIS; HUMANS; IMMUNITY; INFLAMMATION; SYNAPTIC TRANSMISSION; ZINC;

EID: 84922979149     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.11.008     Document Type: Review

References (124)

1. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
2. Hambidge K.M., Krebs N.F. Zinc deficiency: a special challenge. J Nutr 2007, 137:1101-1105.
3. Rink L., Gabriel P. Zinc and the immune system. Proc Nutr Soc 2000, 59:541-552.
4. Maret W., Li Y. Coordination dynamics of zinc in proteins. Chem Rev 2009, 109:4682-4707.
5. Solomons N.W. Mild human zinc deficiency produces an imbalance between cell-mediated and humoral immunity. Nutr Rev 1998, 56:27-28.
6. Prasad A.S. Zinc: an overview. Nutrition 1995, 11:93-99.
7. Heyneman C.A. Zinc deficiency and taste disorders. Ann Pharmacother 1996, 30:186-187.
8. Trumbo P., Yates A.A., Schlicker S., Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 2001, 101:294-301.
9. MacDonald R.S. The role of zinc in growth and cell proliferation. J Nutr 2000, 130:1500S-1508S.
10. Bridges C.C., Zalups R.K. Molecular and ionic mimicry and the transport of toxic metals. Toxicol Appl Pharmacol 2005, 204:274-308.
11. Liuzzi J.P., Cousins R.J. Mammalian zinc transporters. Annu Rev Nutr 2004, 24:151-172.
12. Eide D.J. Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 2006, 1763:711-722.
13. Taylor K.M., Morgan H.E., Johnson A., Nicholson R.I. Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14. FEBS Lett 2005, 579:427-432.
14. Abdel-Mageed A.B., Oehme F.W. A review on biochemical roles, toxicity and interactions of zinc, copper and iron: IV. Interactions. Vet Hum Toxicol 1990, 32:456-458.
15. Huang L, Tepaamorndech S. The SLC30 family of zinc transporters - a review of current understanding of their biological and pathophysiological roles. Mol Aspects Med 34: 548-60.
16. Qin Y., Thomas D., Fontaine C.P., Colvin R.A. Silencing of ZnT1 reduces Zn2+ efflux in cultured cortical neurons. Neurosci Lett 2009, 450:206-210.
17. Lim Y., Levy M., Bray T.M. Dietary zinc alters early inflammatory responses during cutaneous wound healing in weanling CD-1 mice. J Nutr 2004, 134:811-816.
18. Fernandez E.L., Dencker L., Tallkvist J. Expression of ZnT-1 (Slc30a1) and MT-1 (Mt1) in the conceptus of cadmium treated mice. Reprod Toxicol 2007, 24:353-358.
19. Kambe T., Narita H., Yamaguchi-Iwai Y., Hirose J., Amano T., Sugiura N., et al. Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells. J Biol Chem 2002, 277:19049-19055.
20. Chowanadisai W., Lonnerdal B., Kelleher S.L. Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J Biol Chem 2006, 281:39699-39707.
21. Suzuki T., Ishihara K., Migaki H., Matsuura W., Kohda A., Okumura K., et al. Zinc transporters, ZnT5 and ZnT7, are required for the activation of alkaline phosphatases, zinc-requiring enzymes that are glycosylphosphatidylinositol-anchored to the cytoplasmic membrane. J Biol Chem 2005, 280:637-643.
22. Maret W., Krezel A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol Med 2007, 13:371-375.
23. Blewett H.J., Taylor C.G. Dietary zinc deficiency in rodents: effects on T-cell development, maturation and phenotypes. Nutrients 2012, 4:449-466.
24. Monia B.P., Butt T.R., Ecker D.J., Mirabelli C.K., Crooke S.T. Metallothionein turnover in mammalian cells. Implications in metal toxicity. J Biol Chem 1986, 261:10957-10959.
25. Carpene E., Andreani G., Isani G. Metallothionein functions and structural characteristics. J Trace Elem Med Biol 2007, 21(Suppl. 1):35-39.
26. Bell S.G., Vallee B.L. The metallothionein/thionein system: an oxidoreductive metabolic zinc link. Chembiochem 2009, 10:55-62.
27. Gunzel D., Zimmermann F., Durry S., Schlue W.R. Apparent intracellular Mg2+ buffering in neurons of the leech Hirudo medicinalis. Biophys J 2001, 80:1298-1310.
28. Gunther V., Lindert U., Schaffner W. The taste of heavy metals: gene regulation by MTF-1. Biochim Biophys Acta 1823, 2012:1416-1425.
29. Aaseth J., Haugen M., Forre O. Rheumatoid arthritis and metal compounds-perspectives on the role of oxygen radical detoxification. Analyst 1998, 123:3-6.
30. Prasad A.S. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis 2000, 182(Suppl. 1):S62-S68.
31. Guerrerio A.L., Berg J.M. Metal ion affinities of the zinc finger domains of the metal responsive element-binding transcription factor-1 (MTF1). Biochemistry 2004, 43:5437-5444.
32. Wimmer U., Wang Y., Georgiev O., Schaffner W. Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione. Nucleic Acids Res 2005, 33:5715-5727.
33. Auld D.S. The ins and outs of biological zinc sites. Biometals 2009, 22:141-148.
34. Vallee B.L., Auld D.S. Cocatalytic zinc motifs in enzyme catalysis. Proc Natl Acad Sci U S A 1993, 90:2715-2718.
35. Maret W. Zinc and the zinc proteome. Met Ions Life Sci 2013, 12:479-501.
36. Fukada T., Yamasaki S., Nishida K., Murakami M., Hirano T. Zinc homeostasis and signaling in health and diseases: zinc signaling. J Biol Inorg Chem 2011, 16:1123-1134.
37. Yamasaki S., Sakata-Sogawa K., Hasegawa A., Suzuki T., Kabu K., Sato E., et al. Zinc is a novel intracellular second messenger. J Cell Biol 2007, 177:637-645.
38. Hirano T., Murakami M., Fukada T., Nishida K., Yamasaki S., Suzuki T. Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv Immunol 2008, 97:149-176.
39. Grummt F., Weinmann-Dorsch C., Schneider-Schaulies J., Lux A. Zinc as a second messenger of mitogenic induction. Effects on diadenosine tetraphosphate (Ap4A) and DNA synthesis. Exp Cell Res 1986, 163:191-200.
40. Beyersmann D., Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals 2001, 14:331-341.
41. Shankar A.H., Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998, 68:447S-463S.
42. Apostolova M.D., Ivanova I.A., Cherian M.G. Signal transduction pathways, and nuclear translocation of zinc and metallothionein during differentiation of myoblasts. Biochem Cell Biol 2000, 78:27-37.
43. Haase H., Beyersmann D. Uptake and intracellular distribution of labile and total Zn(II) in C6 rat glioma cells investigated with fluorescent probes and atomic absorption. Biometals 1999, 12:247-254.
44. Schmidt C., Beyersmann D. Transient peaks in zinc and metallothionein levels during differentiation of 3T3L1 cells. Arch Biochem Biophys 1999, 364:91-98.
45. Prasad A.S. Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr 2013, 4:176-190.
46. Turvey SE, Broide DH. Innate immunity. J Allergy Clin Immunol 125:S24-32.
47. Haase H, Rink L. Zinc signals and immune function. Biofactors.
48. Ibs K.H., Rink L. Zinc-altered immune function. J Nutr 2003, 133:1452S-1456S.
49. Hujanen E.S., Seppa S.T., Virtanen K. Polymorphonuclear leukocyte chemotaxis induced by zinc, copper and nickel in vitro. Biochim Biophys Acta 1995, 1245:145-152.
50. Sheikh A., Shamsuzzaman S., Ahmad S.M., Nasrin D., Nahar S., Alam M.M., et al. Zinc influences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea. J Nutr 2010, 140:1049-1056.
51. Merithew E., Stone C., Eathiraj S., Lambright D.G. Determinants of Rab5 interaction with the N terminus of early endosome antigen 1. J Biol Chem 2003, 278:8494-8500.
52. Simonsen A., Lippe R., Christoforidis S., Gaullier J.M., Brech A., Callaghan J., et al. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature 1998, 394:494-498.
53. Hasegawa H., Suzuki K., Suzuki K., Nakaji S., Sugawara K. Effects of zinc on the reactive oxygen species generating capacity of human neutrophils and on the serum opsonic activity in vitro. Luminescence 2000, 15:321-327.
54. Chavakis T., May A.E., Preissner K.T., Kanse S.M. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and beta2-integrins. Blood 1999, 93:2976-2983.
55. Mayer L.S., Uciechowski P., Meyer S., Schwerdtle T., Rink L., Haase H. Differential impact of zinc deficiency on phagocytosis, oxidative burst, and production of pro-inflammatory cytokines by human monocytes. Metallomics 2014, 6:1288-1295.
56. Muzzioli M., Stecconi R., Donnini A., Re F., Provinciali M. Zinc improves the development of human CD34+ cell progenitors towards natural killer cells and induces the expression of GATA-3 transcription factor. Int J Biochem Cell Biol 2007, 39:955-965.
57. King L.E., Frentzel J.W., Mann J.J., Fraker P.J. Chronic zinc deficiency in mice disrupted T cell lymphopoiesis and erythropoiesis while B cell lymphopoiesis and myelopoiesis were maintained. J Am Coll Nutr 2005, 24:494-502.
58. Kitabayashi C., Fukada T., Kanamoto M., Ohashi W., Hojyo S., Atsumi T., et al. Zinc suppresses Th17 development via inhibition of STAT3 activation. Int Immunol 2010, 22:375-386.
59. Honscheid A., Dubben S., Rink L., Haase H. Zinc differentially regulates mitogen-activated protein kinases in human T cells. J Nutr Biochem 2012, 23:18-26.
60. Wu C., Pot C., Apetoh L., Thalhamer T., Zhu B., Murugaiyan G., et al. Metallothioneins negatively regulate IL-27-induced type 1 regulatory T-cell differentiation. Proc Natl Acad Sci U S A 2013, 110:7802-7807.
61. Stefanidou M., Maravelias C., Dona A., Spiliopoulou C. Zinc: a multipurpose trace element. Arch Toxicol 2006, 80:1-9.
62. DePasquale-Jardieu P., Fraker P.J. Interference in the development of a secondary immune response in mice by zinc deprivation: persistence of effects. J Nutr 1984, 114:1762-1769.
63. Albert M.J., Qadri F., Wahed M.A., Ahmed T., Rahman A.S., Ahmed F., et al. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis 2003, 187:909-913.
64. Qadri F., Ahmed T., Wahed M.A., Ahmed F., Bhuiyan N.A., Rahman A.S., et al. Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine. Vaccine 2004, 22:416-421.
65. Summersgill H., England H., Lopez-Castejon G., Lawrence C.B., Luheshi N.M., Pahle J., et al. Zinc depletion regulates the processing and secretion of IL-1beta. Cell Death Dis 2014, 5:e1040.
66. Dore-Duffy P., Peterson M., Catalanotto F., Marlow S., Ho S.Y., Ostrom M., et al. Zinc profiles in rheumatoid arthritis. Clin Exp Rheumatol 1990, 8:541-546.
67. Mariani E., Cattini L., Neri S., Malavolta M., Mocchegiani E., Ravaglia G., et al. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerontology 2006, 7:449-459.
68. Gruber K., Maywald M., Rosenkranz E., Haase H., Plumakers B., Rink L. Zinc deficiency adversely influences interleukin-4 and interleukin-6 signaling. J Biol Regul Homeost Agents 2013, 27:661-671.
69. Bhutia D.T. Protein Energy Malnutrition in India: The Plight of Our Under Five Children. J Family Med, Prim Care 2014, 3:63-67.
70. Maret W., Sandstead H.H. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006, 20:3-18.
71. Chandel G., Datta K., Datta S.K. Detection of genomic changes in transgenic Bt rice populations through genetic fingerprinting using amplified fragment length polymorphism (AFLP). GM crops 2010, 1:327-336.
72. Evans G.W. Zinc and its deficiency diseases. Clin Physiol Biochem 1986, 4:94-98.
73. Foster M., Samman S. Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients 2012, 4:676-694.
74. Prasad A.S. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 2009, 12:646-652.
75. Andrews G.K. Regulation and function of Zip4, the acrodermatitis enteropathica gene. Biochem Soc Trans 2008, 36:1242-1246.
76. Simkin P.A. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976, 2:539-542.
77. Mattingly P.C., Mowat A.G. Zinc sulphate in rheumatoid arthritis. Ann Rheum Dis 1982, 41:456-457.
78. Rasker J.J., Kardaun S.H. Lack of beneficial effect of zinc sulphate in rheumatoid arthritis. Scand J Rheumatol 1982, 11:168-170.
79. Zoli A., Altomonte L., Caricchio R., Galossi A., Mirone L., Ruffini M.P., et al. Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha. Clin Rheumatol 1998, 17:378-382.
80. Bao B., Prasad A.S., Beck F.W., Godmere M. Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 2003, 285:E1095-E1102.
81. von Bulow V., Rink L., Haase H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate. J Immunol 2005, 175:4697-4705.
82. Burrage P.S., Mix K.S., Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11:529-543.
83. Filippin L.I., Vercelino R., Marroni N.P., Xavier R.M. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 2008, 152:415-422.
84. Johnson F.O., Yuan Y., Hajela R.K., Chitrakar A., Parsell D.M., Atchison W.D. Exposure to an environmental neurotoxicant hastens the onset of amyotrophic lateral sclerosis-like phenotype in human Cu2+/Zn2+ superoxide dismutase 1 G93A mice: glutamate-mediated excitotoxicity. J Pharmacol Exp Ther 2011, 338:518-527.
85. Costello L.C., Liu Y., Zou J., Franklin R.B. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem 1999, 274:17499-17504.
86. Cao J., Bobo J.A., Liuzzi J.P., Cousins R.J. Effects of intracellular zinc depletion on metallothionein and ZIP2 transporter expression and apoptosis. J Leukoc Biol 2001, 70:559-566.
87. Wang F., Kim B.E., Petris M.J., Eide D.J. The mammalian Zip5 protein is a zinc transporter that localizes to the basolateral surface of polarized cells. J Biol Chem 2004, 279:51433-51441.
88. Taylor K.M., Nicholson R.I. The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim Biophys Acta 2003, 1611:16-30.
89. Taylor K.M., Vichova P., Jordan N., Hiscox S., Hendley R., Nicholson R.I. ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells. Endocrinology 2008, 149:4912-4920.
90. Liu M.J., Bao S., Galvez-Peralta M., Pyle C.J., Rudawsky A.C., Pavlovicz R.E., et al. ZIP8 regulates host defense through zinc-mediated inhibition of NF-kappaB. Cell Rep 2013, 3:386-400.
91. Thevenod F. Catch me if you can! Novel aspects of cadmium transport in mammalian cells. Biometals 2013, 23:857-875.
92. Song J., Kim D., Lee C.H., Lee M.S., Chun C.H., Jin E.J. MicroRNA-488 regulates zinc transporter SLC39A8/ZIP8 during pathogenesis of osteoarthritis. J Biomed Sci 2013, 20:31.
93. Taniguchi M., Fukunaka A., Hagihara M., Watanabe K., Kamino S., Kambe T., et al. Essential role of the zinc transporter ZIP9/SLC39A9 in regulating the activations of Akt and Erk in B-cell receptor signaling pathway in DT40 cells. PLoS One 2013, 8:e58022.
94. Kagara N., Tanaka N., Noguchi S., Hirano T. Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells. Cancer Sci 2007, 98:692-697.
95. Yu Y., Wu A., Zhang Z., Yan G., Zhang F., Zhang L., et al. Characterization of the GufA subfamily member SLC39A11/Zip11 as a zinc transporter. J Nutr Biochem 2013, 24:1697-1708.
96. Martin A.B., Aydemir T.B., Guthrie G.J., Samuelson D.A., Chang S.M., Cousins R.J. Gastric and colonic zinc transporter ZIP11 (Slc39a11) in mice responds to dietary zinc and exhibits nuclear localization. J Nutr 2013, 143:1882-1888.
97. Bly M. Examination of the zinc transporter gene, SLC39A12. Schizophr Res 2006, 81:321-322.
98. Jeong J., Walker J.M., Wang F., Park J.G., Palmer A.E., Giunta C., et al. Promotion of vesicular zinc efflux by ZIP13 and its implications for spondylocheiro dysplastic Ehlers-Danlos syndrome. Proc Natl Acad Sci USA 2012, 109:E3530-E3538.
99. Kirschke C.P., Huang L. ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J Biol Chem 2003, 278:4096-4102.
100. Chen J., Qu N., Xia Y.M. Effect of zinc on thymulin level in mice. Wei Sheng Yan Jiu 2005, 34:430-432.
101. Gumulec J., Raudenska M., Adam V., Kizek R., Masarik M. Metallothionein-immunohistochemical cancer biomarker: a meta-analysis. PLoS One 2014, 9:e85346.
102. Pountney D.L., Dickson T.C., Power J.H., Vickers J.C., West A.J., Gai W.P. Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy. Neurotox Res 2011, 19:115-122.
103. Aschner M., West A.K. The role of MT in neurological disorders. J Alzheimers Dis 2005, 8:139-145. [discussion 209-15].
104. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008, 29:391-403.
105. Phan R.T., Saito M., Kitagawa Y., Means A.R., Dalla-Favera R. Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells. Nat Immunol 2007, 8:1132-1139.
106. Karsunky H., Zeng H., Schmidt T., Zevnik B., Kluge R., Schmid K.W., et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet 2002, 30:295-300.
107. Xin A., Nutt S.L., Belz G.T., Kallies A. Blimp1: driving terminal differentiation to a T. Adv Exp Med Biol 2011, 780:85-100.
108. Carpenter A.C., Grainger J.R., Xiong Y., Kanno Y., Chu H.H., Wang L., et al. The transcription factors Thpok and LRF are necessary and partly redundant for T helper cell differentiation. Immunity 2012, 37:622-633.
109. Menghini R., Fiorentino L., Casagrande V., Lauro R., Federici M. The role of ADAM17 in metabolic inflammation. Atherosclerosis 2013, 228:12-17.
110. Nakatani Y., Yamazaki M., Chazin W.J., Yui S. Regulation of S100A8/A9 (calprotectin) binding to tumor cells by zinc ion and its implication for apoptosis-inducing activity. Mediators Inflamm 2005, 2005:280-292.
111. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995, 77:863-868.
112. McQuibban G.A., Gong J.H., Wong J.P., Wallace J.L., Clark-Lewis I., Overall C.M. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002, 100:1160-1167.
113. Zhang K., McQuibban G.A., Silva C., Butler G.S., Johnston J.B., Holden J., et al. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 2003, 6:1064-1071.
114. Marikovsky M., Ziv V., Nevo N., Harris-Cerruti C., Mahler O. Cu/Zn superoxide dismutase plays important role in immune response. J Immunol 2003, 170:2993-3001.
115. West A.P., Shadel G.S., Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol 2011, 11:389-402.
116. Kim J.E., Yoo S.R., Jeong M.G., Ko J.Y., Ro Y.S. Hair zinc levels and the efficacy of oral zinc supplementation in patients with atopic dermatitis. Acta Derm Venereol 2014, 94(5):558-562.
117. Goggs R., Vaughan-Thomas A., Clegg P.D., Carter S.D., Innes J.F., Mobasheri A., et al. Nutraceutical therapies for degenerative joint diseases: a critical review. Crit Rev Food Sci Nutr 2005, 45:145-164.
118. Devirgiliis C., Zalewski P.D., Perozzi G., Murgia C. Zinc fluxes and zinc transporter genes in chronic diseases. Mutat Res 2007, 622:84-93.
119. Allen-Redpath K., Ou O., Beattie J.H., Kwun I.S., Feldmann J., Nixon G.F. Marginal dietary zinc deficiency in vivo induces vascular smooth muscle cell apoptosis in large arteries. Cardiovasc Res 2013, 99:525-534.
120. Abdelhalim M.A., Moussa S.A., Al-Mohy Y.H. Ultraviolet-visible and fluorescence spectroscopy techniques are important diagnostic tools during the progression of atherosclerosis: diet zinc supplementation retarded or delayed atherosclerosis. Biomed Res Int 2013, 2013:652604.
121. Ranaldi G., Ferruzza S., Canali R., Leoni G., Zalewski P.D., Sambuy Y., et al. Intracellular zinc is required for intestinal cell survival signals triggered by the inflammatory cytokine TNFalpha. J Nutr Biochem 2013, 24:967-976.
122. Peretz A., Cantinieaux B., Neve J., Siderova V., Fondu P. Effects of zinc supplementation on the phagocytic functions of polymorphonuclears in patients with inflammatory rheumatic diseases. J Trace Elem Electrolytes Health Dis 1994, 8:189-194.
123. Beattie J.H., Gordon M.J., Duthie S.J., McNeil C.J., Horgan G.W., Nixon G.F., et al. Suboptimal dietary zinc intake promotes vascular inflammation and atherogenesis in a mouse model of atherosclerosis. Mol Nutr Food Res 2012, 56:1097-1105.
124. Loef M., von Stillfried N., Walach H. Zinc diet and Alzheimer's disease: a systematic review. Nutr Neurosci 2012, 15:2-12.